Saturday, 17 October 2026European Markets

AVANCE GAS HOLDING Stock Jumps By 21% In The Last 10 Sessions

Loading stream...

(VIANEWS) - Shares of AVANCE GAS HOLDING (Oslo Børs Benchmark Index_GI: AGAS.OL) rose by a staggering 21.51% in 10 sessions from kr70.2 to kr85.30 at 17:26 EST on Monday, following the last session's upward trend. Oslo Børs Benchmark Index_GI is sliding 0.29% to kr1,215.57, after three sequential sessions in a row of losses.

About AVANCE GAS HOLDING

Avance Gas Holding Ltd, together with its subsidiaries, engages in the transportation of liquefied petroleum gas (LPG). The company transports LPG from the Persian Gulf and the United States Gulf/the United States East Coast to destinations in Europe, South America, India, and Asia. As of December 31, 2022, it owned and operated through a fleet of twelve very large gas carriers and four dual-fuel LPG newbuildings. The company was founded in 2007 and is based in Hamilton, Bermuda. Avance Gas Holding Ltd operates as a subsidiary of Hemen Holding Ltd.

Earnings Per Share

As for profitability, AVANCE GAS HOLDING has a trailing twelve months EPS of kr13.34.

PE Ratio

AVANCE GAS HOLDING has a trailing twelve months price to earnings ratio of 6.39. Meaning, the purchaser of the share is investing kr6.39 for every norwegian krone of annual earnings.

More news about AVANCE GAS HOLDING (AGAS.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com